Prs61 - Assessment of Asthma-Diagnosed Population Eligible for New Monoclonal Antibody Therapy in Veneto Region

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2455
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Monoclonal Antibody Therapy

AAOHN Journal
1987English

A Review of Three New Anti-Interleukin-5 Monoclonal Antibody Therapies for Severe Asthma

Cureus
2018English

Monoclonal Antibody Therapy for Non-Malignant Disease

Australian Prescriber
Pharmacology
2006English

New Possibilities for Asthma Therapy in Children

Medical Council
2018English

P1 Omalizumab in Paediatric Asthma: Importance of Multi-Disciplinary Assessment to Identify Eligible Patients

Thorax
PulmonaryRespiratory Medicine
2012English

Rapid Generation of in Vitro Multicellular Spheroids for the Study of Monoclonal Antibody Therapy

Journal of Cancer
Oncology
2011English

Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis

Clinical and Developmental Immunology
2013English

Advances in Dyslipidemia Management for Prevention of Atherosclerosis: PCSK9 Monoclonal Antibody Therapy and Beyond

Cardiovascular Diagnosis and Therapy
Cardiovascular MedicineCardiology
2017English

Analysis of HLA-D Region-Associated Molecules With Monoclonal Antibody.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1979English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy